imatinib mesylate has been researched along with Cataract in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CL; He, YT; Huang, L; Ji, J; Li, SF; Mei, F; Niu, JQ; Wang, HZ; Zhou, YP | 1 |
1 other study(ies) available for imatinib mesylate and Cataract
Article | Year |
---|---|
Time-specific blockade of PDGFR with Imatinib (GlivecĀ®) causes cataract and disruption of lens fiber cells in neonatal mice.
Topics: Animals; Animals, Newborn; Apoptosis; Benzamides; Cataract; Cell Movement; Cell Proliferation; Disease Models, Animal; Epithelial Cells; Imatinib Mesylate; In Situ Nick-End Labeling; Lens, Crystalline; Mice; Mice, Inbred BALB C; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Signal Transduction; Time Factors | 2011 |